STB
CRL icon

S&T Bank’s Charles River Laboratories CRL Stock Holding History

S&T Bank’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.3K Buy
72
+39
+118% +$6.95K ﹤0.01% 253
2026
Q1 		$5.69K Buy
33
+2
+6% +$371 ﹤0.01% 321
2025
Q4 		$6.18K Buy
31
+15
+94% +$2.72K ﹤0.01% 283
2025
Q3 		$2.5K Hold
16
– – ﹤0.01% 382
2025
Q2 		$2.43K Buy
+16
New +$2.13K ﹤0.01% 368

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

S&T Bank's CRL Position: Q2 2026 in Review

S&T Bank increased its Charles River Laboratories (CRL) stake by 118% in Q2 2026, buying an estimated $6.95K and bringing the position to 72 shares worth $16.3K. The position accounts for ﹤0.01% of the portfolio, ranked #253.

S&T Bank first reported a position in CRL in Q2 2025 and has held it in 5 quarters since. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • S&T Bank held 72 shares of Charles River Laboratories worth $16.3K as of Q2 2026.
  • S&T Bank bought 39 Charles River Laboratories shares in Q2 2026, an estimated $6.95K.
  • Charles River Laboratories made up ﹤0.01% of S&T Bank's portfolio in Q2 2026, its #253 holding.
  • S&T Bank first reported a position in Charles River Laboratories in Q2 2025 and has held it in 5 quarters since.
  • 563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on S&T Bank's 13F filing for Q2 2026, filed 12 Aug 2026.